Statistics for Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration
Total visits
| views | |
|---|---|
| Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration | 222 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| 1.pdf | 157 |
Top country views
| views | |
|---|---|
| United States | 175 |
| Germany | 11 |
| Russia | 6 |
| Ukraine | 6 |
| China | 3 |
| United Kingdom | 3 |
| Canada | 2 |
| Malaysia | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 54 |
| Fairfield | 25 |
| Houston | 16 |
| Ann Arbor | 12 |
| Cambridge | 9 |
| Kiez | 8 |
| Jacksonville | 7 |
| Kiev | 6 |
| Saint Petersburg | 4 |
| San Francisco | 3 |
| Baltimore | 2 |
| Beijing | 2 |
| London | 2 |
| Toronto | 2 |
| Brooklyn | 1 |
| Chicago | 1 |
| Frankfurt Am Main | 1 |
| Gunzenhausen | 1 |
| Kansas City | 1 |
| Lake Mary | 1 |
| Moscow | 1 |
| Mountain View | 1 |
| Netze | 1 |
| New York | 1 |
| Philadelphia | 1 |
| Scottsdale | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Shenzhen | 1 |
| Stockholm | 1 |
| Washington | 1 |